Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 20/20 | 0.79 |
| ▸ | ADAM10 | O14672 | 2/20 | 0.56 |
| ▸ | MMP2 | P08253 | 2/20 | 0.56 |
| ▸ | MMP3 | P08254 | 2/20 | 0.56 |
| ▸ | MMP13 | P45452 | 2/20 | 0.56 |
| ▸ | MMP14 | P50281 | 2/20 | 0.56 |
| ▸ | MMP7 | P09237 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8217793 | 1.00 | ADAM17 (0.79) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8217801 | 0.91 | ADAM17 (0.79) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8219905 | 0.90 | ADAM17 (0.80) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8210503 | 0.90 | ADAM17 (0.80) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8219940 | 0.89 | ADAM17 (0.78) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8219901 | 0.89 | ADAM17 (0.85) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8218124 | 0.89 | ADAM17 (1.00) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8275762 | 0.88 | ADAM17 (0.84) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8276121 | 0.88 | ADAM17 (0.84) | ADAM17ADAM10MMP2MMP3MMP13 | |
| SCHEMBL8219908 | 0.85 | ADAM17 (0.79) | ADAM17ADAM10MMP2MMP3MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005121130-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2005-12-22 | — | — | WO | disclosed |